Larger Dose of Spironolactone for the Treatment of Patients With Nonischemic Cardiomyopathy

This study has been terminated.

( Poor compliance with the therapy and lot of patients were lost to follow up. )

Study NCT00125437 Information provided by Hebei Medical University

First Received: July 29, 2005 Last Updated: July 13, 2009 History of Changes

Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:

Conditions listed in this trial

Additional conditions recognized in this trial

Cardiomyopathies
Heart Failure

More general conditions related to this trial

Interventions listed in this trial

spironolactone

Additional drug interventions recognized in this trial

More general drug interventions related to this trial

Sponsors listed in this trial